News

Results found (480)
June 2, 2017
NewStem & Yissum on i24news TV

Mapping out Cancer cells and how to fight them.
Interview with Ayelet Dilion-Mashiah, NewStem CEO.

May 28, 2017
Lack of infrastructure for later-stage development holds Israeli biotech back

Universities in the country produce plenty of research, much of which can be turned into viable and marketable products. In that, Israel has plenty of experience: Two out of the three oldest university-based technology transfer companies in the...

May 28, 2017
Diabetes and glaucoma startups win big at Biomed competition

Betalin Therapeutics, Nutrino Health, and E-Shunt win top awards in first ever biomed startup competition held at MIXiii Biomed exhibition this week.

May 28, 2017
Israel’s tech startups are giving Silicon Valley a run for its money

Dr. Yaron Daniely, chief executive of Yissum, Hebrew University’s technology transfer arm, and himself the driving force behind many Israeli developments in medical technology, credits the amazing performance of Israeli R&D to “chutzpah,” shown...

May 25, 2017
Israeli startup finds way to predict tumor resistance to chemo

Cancer patients are subject to rounds of chemotherapy treatments in which cells – both healthy and cancerous are expected to be destroyed in the process. 
Now Hebrew University researchers say they have developed a way to predict resistance to...

May 25, 2017
Chickpea: the next plant protein

During the recent Rethinking Food: The Future of Food Innovation event in Tel Aviv, Israel, organised by the Israel Export Institute, Dr Kevin Robinson met with Ram Reifen, a paediatric specialist in gastroenterology and nutrition and a Professor...

May 24, 2017
New technology can predict resistance to chemotherapy

NewStem, a startup based in Jerusalem, is developing a novel diagnostic kit for predicting resistance to chemotherapy treatments. The technology is based on the pioneering research of Prof. Nissim Benvenisty of the Azrieli Center for Stem Cells...

April 18, 2017
Avec Yissum, l'université hébraïque de Jérusalem fait fructifier son...

Yissum, société de valorisation commerciale de l'université hébraïque de Jérusalem, a généré depuis 1964 près de 2 milliards de dollars de chiffre d'affaires. Si elle a misé très tôt sur les sciences de la vie, la structure a élargi son...

April 6, 2017
Move aside peas... chickpea protein has just as much potential, claims...

Soy, rice and peas still dominate the plant-based protein market, but chickpeas could soon give them all a serious run for their money, predicts Israeli start-up CHiCK.P, which is seeking a strategic partner to commercialize its patent-pending...

April 5, 2017
Therapix Signs Exclusive License Agreement with Yissum for Nasal Drug...

Therapix Biosciences Ltd. (NASDAQ, TASE: TRPX), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced that it has signed a sublicense agreement for Yissum Research...

March 15, 2017
Israeli Profs. Use High-tech Ends to Gauge Tourists' Feelings in Jerusalem

You’re a first-time visitor to Jerusalem, what sites are likely to arouse the strongest feelings? Naturally one would be the Western Wall, but how about the Daniel Auster Garden next to city hall?
Prof. Noam Shoval, Yonatan Schvimer and Prof....

March 13, 2017
Intel to Buy Mobileye, Maker of Sensors for Self-Driving Cars, for $15.3 Billion

Intel agreed on Monday to pay $15.3 billion for Mobileye, an Israeli technology company that specializes in making sensors and cameras for autonomous cars, as the global microchip giant tries to expand its reach in the fast-growing sector.

The...